A series of novel 3-substituted-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propenes in order to improve the in vitro and in vivo activity of our prototype 3-[4-(3-chlorophenyl)-1-piperazinyl]-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propene (2) were synthesized and evaluated by assays of growth inhibition against several tumor cell lines in vitro and antitumor activity against some tumor models when dosed both intraperitoneally and orally in vivo. Compounds 7a and 7e, the 3,5-difluorophenyl and 3,5-dichlorophenyl analogues of 2, respectively, showed significantly more potent cytotoxicity than 2 in vitro and potent antitumor activities without causing decrease of body temperature related to side effects.

Download full-text PDF

Source
http://dx.doi.org/10.1248/cpb.50.453DOI Listing

Publication Analysis

Top Keywords

antitumor activity
8
synthesis antitumor
4
activity novel
4
novel pyrimidinyl
4
pyrimidinyl pyrazole
4
pyrazole derivatives
4
derivatives optimization
4
optimization phenylpiperazine
4
phenylpiperazine moiety
4
moiety 1-[5-methyl-1-2-pyrimidinyl-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!